Abstract
The statin medicine is inhibitor HGM-CoA (hydroxymethylglutaryl - Coenzyme A), produces cellular responses like reducing the synthesis of LDL (low density lipoprotein) and VLDL (very low density lipoprotein). The HGM-CoA, from acetyl-CoA, is responsible for the release of mevalonate, an important precursor of cholesterol. So is indicated for the treatment of hyperlipidemia and hypercholes…